Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Enrico Franceschi

Showing results (31-40 of 162) with videos related to

Pageof 17
Sort By:
Cancers|January 21, 2022
Molecular Targeted Therapies: Time for a Paradigm Shift in Medulloblastoma Treatment?Lidia Gatto, Enrico Franceschi, Alicia Tosoni, et al.
Expert Review of Anticancer Therapy|November 4, 2021
Engineered CAR-T and novel CAR-based therapies to fight the immune evasion of glioblastoma: gutta cavat lapidemLidia Gatto, Enrico Franceschi, Vincenzo Di Nunno, et al.
Immunotherapy|June 7, 2022
Hypermutation as a potential predictive biomarker of immunotherapy efficacy in high-grade gliomas: a broken dream?Lidia Gatto, Enrico Franceschi, Alicia Tosoni, et al.
Frontiers in Oncology|July 25, 2022
Tumor-Associated Microenvironment of Adult Gliomas: A ReviewVincenzo Di Nunno, Enrico Franceschi, Alicia Tosoni, et al.
The Oncologist|June 9, 2021
Liquid Biopsy in Glioblastoma Management: From Current Research to Future PerspectivesLidia Gatto, Enrico Franceschi, Vincenzo Di Nunno, et al.
Future Oncology (London, England)|July 24, 2014
Resistance to antiangiogenic therapiesMarco Bartolotti, Enrico Franceschi, Rosalba Poggi, et al.
Expert Review of Anticancer Therapy|December 7, 2013
The role of systemic and targeted therapies in brain metastasesEnrico Franceschi, Marco Bartolotti, Rosalba Poggi, et al.
Expert Review of Clinical Pharmacology|December 28, 2022
How to treat histone 3 altered gliomas: molecular landscape and therapeutic developmentsVincenzo Di Nunno, Enrico Franceschi, Lidia Gatto, et al.
Expert Opinion on Drug Discovery|January 31, 2023
Glioblastoma treatment slowly moves toward change: novel druggable targets and translational horizons in 2022Lidia Gatto, Enrico Franceschi, Alicia Tosoni, et al.
Frontiers in Oncology|March 21, 2022
Glioblastoma Microenvironment: From an Inviolable Defense to a Therapeutic ChanceVincenzo Di Nunno, Enrico Franceschi, Alicia Tosoni, et al.
Pageof 17

Showing results (31-40 of 162) with videos related to

Sort By:
Pageof 17
Cancers|January 21, 2022
Molecular Targeted Therapies: Time for a Paradigm Shift in Medulloblastoma Treatment?Lidia Gatto, Enrico Franceschi, Alicia Tosoni, et al.
Expert Review of Anticancer Therapy|November 4, 2021
Engineered CAR-T and novel CAR-based therapies to fight the immune evasion of glioblastoma: gutta cavat lapidemLidia Gatto, Enrico Franceschi, Vincenzo Di Nunno, et al.
Immunotherapy|June 7, 2022
Hypermutation as a potential predictive biomarker of immunotherapy efficacy in high-grade gliomas: a broken dream?Lidia Gatto, Enrico Franceschi, Alicia Tosoni, et al.
Frontiers in Oncology|July 25, 2022
Tumor-Associated Microenvironment of Adult Gliomas: A ReviewVincenzo Di Nunno, Enrico Franceschi, Alicia Tosoni, et al.
The Oncologist|June 9, 2021
Liquid Biopsy in Glioblastoma Management: From Current Research to Future PerspectivesLidia Gatto, Enrico Franceschi, Vincenzo Di Nunno, et al.
Future Oncology (London, England)|July 24, 2014
Resistance to antiangiogenic therapiesMarco Bartolotti, Enrico Franceschi, Rosalba Poggi, et al.
Expert Review of Anticancer Therapy|December 7, 2013
The role of systemic and targeted therapies in brain metastasesEnrico Franceschi, Marco Bartolotti, Rosalba Poggi, et al.
Expert Review of Clinical Pharmacology|December 28, 2022
How to treat histone 3 altered gliomas: molecular landscape and therapeutic developmentsVincenzo Di Nunno, Enrico Franceschi, Lidia Gatto, et al.
Expert Opinion on Drug Discovery|January 31, 2023
Glioblastoma treatment slowly moves toward change: novel druggable targets and translational horizons in 2022Lidia Gatto, Enrico Franceschi, Alicia Tosoni, et al.
Frontiers in Oncology|March 21, 2022
Glioblastoma Microenvironment: From an Inviolable Defense to a Therapeutic ChanceVincenzo Di Nunno, Enrico Franceschi, Alicia Tosoni, et al.
Pageof 17